170 related articles for article (PubMed ID: 10160471)
1. Pharmacoeconomics of Pneumocystis carinii pneumonia in HIV-infected and HIV-noninfected patients.
Nicolau DP; Ross JW; Quintiliani R; Nightingale CH
Pharmacoeconomics; 1996 Jul; 10(1):72-8. PubMed ID: 10160471
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness models of clinical trials of new pharmaceuticals for AIDS-related Pneumocystis carinii pneumonia: are they helpful to policy makers?
Bennett CL; Oddone E; Matchar D
Clin Perform Qual Health Care; 1995; 3(3):156-64. PubMed ID: 10151167
[TBL] [Abstract][Full Text] [Related]
3. Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia.
Zarkin GA; Bala MV; Wood LL; Bennett CL; Simpson K; Dohn MN
Pharmacoeconomics; 1996 Jun; 9(6):525-34. PubMed ID: 10160480
[TBL] [Abstract][Full Text] [Related]
4. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
González-García J; Rubio García R; Antela López A; García Alcaide F
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
[TBL] [Abstract][Full Text] [Related]
5. Analysis of life-long strategies to prevent Pneumocystis carinii pneumonia in patients with variable HIV progression rates.
Wynia MK; Ioannidis JP; Lau J
AIDS; 1998 Jul; 12(11):1317-25. PubMed ID: 9708411
[TBL] [Abstract][Full Text] [Related]
6. [Pneumocystis carinii pneumonia in AIDS: retrospective analysis of 80 documented cases (1985-1993)].
Morlat P; Bartou C; Ragnaud JM; Dequae L; Lacoste D; Buisson M; Bernard N; Mercié P; Couprie B; Beylot J; Aubertin J
Rev Med Interne; 1996; 17(1):25-33. PubMed ID: 8677382
[TBL] [Abstract][Full Text] [Related]
7. Primary prophylaxis for Pneumocystis carinii pneumonia: a randomized trial comparing cotrimoxazole, aerosolized pentamidine and dapsone plus pyrimethamine.
Mallolas J; Zamora L; Gatell JM; Miró JM; Vernet E; Valls ME; Soriano E; SanMiguel JG
AIDS; 1993 Jan; 7(1):59-64. PubMed ID: 8442918
[TBL] [Abstract][Full Text] [Related]
8. The impact of prophylaxis on outcome and resource utilization in Pneumocystis carinii pneumonia.
Gallant JE; McAvinue SM; Moore RD; Bartlett JG; Stanton DL; Chaisson RE
Chest; 1995 Apr; 107(4):1018-23. PubMed ID: 7705108
[TBL] [Abstract][Full Text] [Related]
9. A controlled trial of aerosolized pentamidine or trimethoprim-sulfamethoxazole as primary prophylaxis against Pneumocystis carinii pneumonia in patients with human immunodeficiency virus infection. The Dutch AIDS Treatment Group.
Schneider MM; Hoepelman AI; Eeftinck Schattenkerk JK; Nielsen TL; van der Graaf Y; Frissen JP; van der Ende IM; Kolsters AF; Borleffs JC
N Engl J Med; 1992 Dec; 327(26):1836-41. PubMed ID: 1360145
[TBL] [Abstract][Full Text] [Related]
10. Pneumocystis pneumonia in South African children diagnosed by molecular methods.
Morrow BM; Samuel CM; Zampoli M; Whitelaw A; Zar HJ
BMC Res Notes; 2014 Jan; 7():26. PubMed ID: 24410938
[TBL] [Abstract][Full Text] [Related]
11. Pneumocystis pneumonia--a retrospective study 1991-2001 in Gothenburg, Sweden.
Mikaelsson L; Jacobsson G; Andersson R
J Infect; 2006 Oct; 53(4):260-5. PubMed ID: 16403575
[TBL] [Abstract][Full Text] [Related]
12. Comparison of trimethoprim-sulfamethoxazole, dapsone, and pentamidine in the prophylaxis of Pneumocystis carinii pneumonia.
Warnock AC; Rimland D
Pharmacotherapy; 1996; 16(6):1030-8. PubMed ID: 8947975
[TBL] [Abstract][Full Text] [Related]
13. Good outcome with trimethoprim 10 mg/kg/day-sulfamethoxazole 50 mg/kg/day for Pneumocystis jirovecii pneumonia in HIV infected patients.
Thomas M; Rupali P; Woodhouse A; Ellis-Pegler R
Scand J Infect Dis; 2009; 41(11-12):862-8. PubMed ID: 19922070
[TBL] [Abstract][Full Text] [Related]
14. Use of adjunctive corticosteroids in severe adult non-HIV Pneumocystis carinii pneumonia.
Pareja JG; Garland R; Koziel H
Chest; 1998 May; 113(5):1215-24. PubMed ID: 9596297
[TBL] [Abstract][Full Text] [Related]
15. Complications during clinical courses of Pneumocystis carinii pneumonia in patients with acquired immunodeficiency syndrome.
Teruya K; Yasuoka A; Yamaguchi M; Yasuoka C; Yamamoto Y; Genka I; Tachikawa N; Kikuchi Y; Oka S
Intern Med; 2001 Mar; 40(3):221-6. PubMed ID: 11310488
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection.
Briel M; Bucher HC; Boscacci R; Furrer H
Cochrane Database Syst Rev; 2006 Jul; (3):CD006150. PubMed ID: 16856118
[TBL] [Abstract][Full Text] [Related]
17. [Incidence of bacterial pneumonia in HIV-positive patients treated with preventive co-trimoxazole or pentamidine].
Koch A; Kothe H; Braun J; Kämmerer R; Friedrich HJ; Dalhoff K
Pneumologie; 1998 Nov; 52(11):614-21. PubMed ID: 9885511
[TBL] [Abstract][Full Text] [Related]
18. Pneumocystis carinii pneumonia. Review of 32 cases in immunocompromised hosts.
de Hoon JN; Peetermans WE; Bobbaers HJ
Acta Clin Belg; 1997; 52(1):19-26. PubMed ID: 9085615
[TBL] [Abstract][Full Text] [Related]
19. Treatment of Pneumocystis jirovecii pneumonia in HIV-infected patients: a review.
Huang YS; Yang JJ; Lee NY; Chen GJ; Ko WC; Sun HY; Hung CC
Expert Rev Anti Infect Ther; 2017 Sep; 15(9):873-892. PubMed ID: 28782390
[TBL] [Abstract][Full Text] [Related]
20. Pneumocystis carinii pneumonia in HIV/AIDS patients at an urban district hospital in Kenya.
Chakaya JM; Bii C; Ng'ang'a L; Amukoye E; Ouko T; Muita L; Gathua S; Gitau J; Odongo I; Kabanga JM; Nagai K; Suzumura S; Sugiura Y
East Afr Med J; 2003 Jan; 80(1):30-5. PubMed ID: 12755239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
